Showing results (71-80 of 408) with videos related to
Sort By:
Pageof 41
Experimental Hematology|May 27, 2006
Oncolytic measles virus targets high CD46 expression on multiple myeloma cellsHooi Tin Ong, Michael M Timm, Philip R Greipp, et al.Blood|February 11, 2012
Elevated serum IL-10 levels in diffuse large B-cell lymphoma: a mechanism of aberrant JAK2 activationMamta Gupta, Jing Jing Han, Mary Stenson, et al.American Journal of Hematology|January 3, 2014
Elevated serum monoclonal and polyclonal free light chains and interferon inducible protein-10 predicts inferior prognosis in untreated diffuse large B-cell lymphomaThomas E Witzig, Matthew J Maurer, Mary J Stenson, et al.Current Stem Cell Research & Therapy|January 29, 2008
Use of radioimmunotherapy in stem cell transplantation and posttransplantation: focus on yttrium 90 ibritumomab tiuxetanArturo Molina, Amrita Krishnan, Henry Fung, et al.Blood|June 16, 2011
Cytotoxicity of farnesyltransferase inhibitors in lymphoid cells mediated by MAPK pathway inhibition and Bim up-regulationHusheng Ding, Jennifer Hackbarth, Paula A Schneider, et al.Future Oncology (London, England)|April 19, 2016
ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphomaGrzegorz S Nowakowski, Annalisa Chiappella, Thomas E Witzig, et al.Haematologica|August 24, 2014
Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphomaThomas E Witzig, Michael B Tomblyn, Jamal G Misleh, et al.Cancer|February 19, 2010
The treatment of recurrent/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL) with everolimus results in clinical responses and mobilization of CLL cells into the circulationClive S Zent, Betsy R LaPlant, Patrick B Johnston, et al.Blood|July 2, 2011
Soluble IL-2Rα facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphomaZhi-Zhang Yang, Deanna M Grote, Steven C Ziesmer, et al.Leukemia & Lymphoma|March 13, 2023
Functional humoral and cellular response of monovalent COVID-19-vaccines against Omicron BA.2 variant of SARS-CoV-2 in patients with chronic lymphocytic leukemiaMatteo Passerini, Tamar Ratishvili, Jonathon M Monroe, et al.Pageof 41